Results
88
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
88 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
CALTX | SEK 206.80 | 0% | 105.8% | SEK 11.2b | SEK 225.00 | PS8.5x | E53.7% | n/a | Pharmaceuticals & Biotech | ||
KEBNI B | SEK 1.51 | 4.1% | 10.1% | SEK 408.9m | SEK 2.20 | PS4.4x | E90.4% | n/a | Tech | ||
YUBICO | SEK 239.50 | 4.1% | 136.2% | SEK 20.6b | SEK 267.50 | PE124.5x | E43.8% | n/a | Software | ||
MAGLE | SEK 39.20 | -3.0% | 17.4% | SEK 423.4m | SEK 50.00 | PE55x | E72.2% | n/a | Pharmaceuticals & Biotech | ||
CTT | SEK 284.00 | 4.4% | 33.3% | SEK 3.6b | n/a | PE34.9x | E24.8% | 1.9% | Capital Goods | ||
YIELD | SEK 2.20 | -7.2% | -67.6% | SEK 126.0m | SEK 9.00 | PB1.5x | E103.4% | n/a | Diversified Financials | ||
EDYOU | SEK 1.64 | 31.9% | 30.4% | SEK 66.3m | n/a | PS2x | E63.1% | n/a | Media | ||
BIOA B | SEK 151.50 | -6.8% | -52.6% | SEK 13.4b | SEK 320.40 | PS53.1x | E102.1% | 0% | Pharmaceuticals & Biotech | ||
BIOVIC B | SEK 2.68 | -2.5% | -66.5% | SEK 225.3m | SEK 7.90 | PS30.9x | E73.8% | n/a | Pharmaceuticals & Biotech | ||
INCOAX | SEK 2.23 | -1.8% | -29.2% | SEK 241.2m | SEK 3.65 | PS2.5x | E104.9% | n/a | Tech | ||
CRAD B | SEK 44.20 | 1.7% | 39.7% | SEK 1.5b | SEK 57.00 | PE27.8x | E33.9% | n/a | Healthcare | ||
ORGC | SEK 3.25 | 1.9% | -27.3% | SEK 318.9m | SEK 3.00 | PS2.3x | E109.0% | n/a | Materials | ||
FLEXQ | SEK 10.30 | -1.0% | -46.9% | SEK 138.1m | SEK 25.00 | PS1.2x | E118.7% | n/a | Capital Goods | ||
ESGR B | SEK 30.50 | 3.2% | -54.9% | SEK 200.9m | SEK 58.00 | PS1.1x | E57.0% | n/a | Household | ||
CTM | SEK 6.00 | -2.3% | -73.6% | SEK 453.9m | SEK 29.70 | PB0.2x | E115.4% | 0% | Media | ||
MIDS | SEK 1.20 | -5.2% | -41.0% | SEK 252.5m | SEK 2.80 | PS3.9x | E89.9% | n/a | Semiconductors | ||
KLAR | SEK 0.37 | -2.4% | -22.7% | SEK 48.1m | SEK 1.00 | PB1.6x | E61.3% | n/a | Pharmaceuticals & Biotech | ||
SENZA | SEK 7.10 | 2.2% | -27.6% | SEK 209.5m | SEK 16.50 | PS4x | E67.8% | n/a | Pharmaceuticals & Biotech | ||
TRUE B | SEK 33.22 | 0.9% | -8.2% | SEK 11.5b | SEK 54.83 | PE24x | E21.5% | 1.2% | Software | ||
EQT | SEK 320.00 | 1.6% | 37.9% | SEK 378.3b | SEK 360.99 | PE109.5x | E56.9% | 1.1% | Diversified Financials | ||
4C | SEK 19.85 | -5.9% | -18.6% | SEK 697.4m | SEK 22.00 | PS2.4x | E108.0% | n/a | Software | ||
NIUTEC | SEK 6.14 | 0.7% | -44.0% | SEK 125.1m | SEK 9.50 | PB1.5x | E94.1% | n/a | Capital Goods | ||
FNOX | SEK 55.00 | -12.3% | -10.6% | SEK 33.5b | SEK 73.00 | PE51.6x | E22.6% | 0.4% | Software | ||
EGTX | SEK 5.88 | 1.6% | 30.7% | SEK 1.7b | SEK 13.30 | PS27.4x | E98.6% | n/a | Pharmaceuticals & Biotech |